These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Strategies and challenges involved in the discovery of new chemical entities during early-stage tuberculosis drug discovery. Coxon GD; Cooper CB; Gillespie SH; McHugh TD J Infect Dis; 2012 May; 205 Suppl 2():S258-64. PubMed ID: 22448016 [TBL] [Abstract][Full Text] [Related]
5. Discovery and validation of new antitubercular compounds as potential drug leads and probes. Goldman RC; Laughon BE Tuberculosis (Edinb); 2009 Sep; 89(5):331-3. PubMed ID: 19716767 [TBL] [Abstract][Full Text] [Related]
7. New anti-tuberculosis agents amongst known drugs. Lougheed KE; Taylor DL; Osborne SA; Bryans JS; Buxton RS Tuberculosis (Edinb); 2009 Sep; 89(5):364-70. PubMed ID: 19699151 [TBL] [Abstract][Full Text] [Related]
8. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem. Goldman RC Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384 [TBL] [Abstract][Full Text] [Related]
9. The future for early-stage tuberculosis drug discovery. Zuniga ES; Early J; Parish T Future Microbiol; 2015; 10(2):217-29. PubMed ID: 25689534 [TBL] [Abstract][Full Text] [Related]
10. High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv. Reynolds RC; Ananthan S; Faaleolea E; Hobrath JV; Kwong CD; Maddox C; Rasmussen L; Sosa MI; Thammasuvimol E; White EL; Zhang W; Secrist JA Tuberculosis (Edinb); 2012 Jan; 92(1):72-83. PubMed ID: 21708485 [TBL] [Abstract][Full Text] [Related]
11. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model. Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471 [TBL] [Abstract][Full Text] [Related]
12. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis. Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944 [TBL] [Abstract][Full Text] [Related]
15. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019 [TBL] [Abstract][Full Text] [Related]
16. Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discovery. Ekins S; Freundlich JS; Hobrath JV; Lucile White E; Reynolds RC Pharm Res; 2014 Feb; 31(2):414-35. PubMed ID: 24132686 [TBL] [Abstract][Full Text] [Related]
17. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors. Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832 [TBL] [Abstract][Full Text] [Related]
18. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS. Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106 [TBL] [Abstract][Full Text] [Related]
19. Novel and revisited approaches in antituberculosis drug discovery. Herrmann J; Rybniker J; Müller R Curr Opin Biotechnol; 2017 Dec; 48():94-101. PubMed ID: 28427007 [TBL] [Abstract][Full Text] [Related]
20. Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages. Han HW; Seo HH; Jo HY; Han HJ; Falcão VCA; Delorme V; Heo J; Shum D; Choi JH; Lee JM; Lee SH; Heo HR; Hong SH; Park MH; Thimmulappa RK; Kim JH Stem Cell Reports; 2019 Dec; 13(6):980-991. PubMed ID: 31680058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]